Keywords: Alzheimer's disease, Market forecasts, Eli Lilly, Bapineuzumab, Johnson & Johnson, Pfizer, Solanezumab

Alzheimer’s drug market to triple to $14.3 billion by 2020, says DR

Article | 09 October 2011

Print This

The Alzheimer’s disease drug market will nearly triple over the next 10 years, increasing from $5.4 billion in 2010 to $14.3 billion ...

Enjoying this article? To continue reading you need to login or subscribe.

Subscribe now
for unlimited access to all articles

Subscriptions are £60 per month, pay as you go.
Find out more details.

Already a subscriber? Click here to log in